Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 1;16(1):1229.
doi: 10.1007/s12672-025-03006-z.

Single nucleotide polymorphism and expression of P16 gene as a potential biomarker for oral and pre-oral cancer

Affiliations

Single nucleotide polymorphism and expression of P16 gene as a potential biomarker for oral and pre-oral cancer

Kumud Nigam et al. Discov Oncol. .

Abstract

Objective: This study investigated the association between p16 gene and its 450 C > G (rs11515) polymorphism with risk of oral cancer and precancerous oral lesions/oral potentially malignant disorder (OPMD).

Method: The study included 230 individuals with OPMD conditions (70 with leukoplakia, 90 with oral submucous fibrosis, and 70 with lichen planus), 72 oral cancer patients, and 300 cancer-free healthy controls. Genotyping of the p16 450 C > G polymorphism was conducted using PCR-RFLP methods, and genotype and allele frequencies were analyzed using chi-square test. Additionally, p16 gene expression levels were measured using RT-PCR among oral cancer patients, those with OPMD, and healthy controls. RNA fold was used to calculate the MFE of p16 mRNA.

Results: The findings revealed that G allele of p16 450 C > G polymorphism significantly increased risk of oral diseases (oral cancer and OPMD) compared to C allele (OR 1.67, p = 0.0001). GG genotype was associated with higher risk of oral submucous fibrosis (OR 4.63, p = 0.0001), lichenplanus (OR 3.93, p = 0.0002), and leukoplakia (OR 2.38, p = 0.02) compared to CC genotype. Smokers and tobacco chewers carrying the G allele were at a significantly increased risk of developing OPMD (OR = 3.78 and 2.89). Notably, p16 transcript expression was significantly elevated (13.56-fold) in oral cancer patients compared to healthy controls. According to insilco analysis G allele gives more stable transcript of p16 (MEF - 64.90 kcal/mol) compared to C allele (MFE - 61.70 kcal/mol).

Conclusion: These findings suggest that p16 gene and its 450 C > G polymorphism may be associated with risk of oral diseases, indicating their potential utility as biomarkers for these conditions.

Keywords: P16; OPMD; Oral cancer; Polymorphism.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethical approval: Ethical approval for this study was obtained from the Ethical Committee of King George’s Medical University, Lucknow named as Institutional Ethics Committee (Registration No: ECR/262/Inst/UP/2013) under approval number 85th ECM II B- Ph.D./P2. This study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki. Consent to participate: Informed consents (Consent to Participate) were obtained from all participants or, if participants are under 18, from a parent and/or legal guardian. Consent for publication: Consent to Publish were obtained from all participants or, if participants are under 18, from a parent and/or legal guardian. All authors have given their consent to publish this work. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Frequency distributions of different genotypes and allele of p16 450 C > G polymorphism among the subjects of healthy control, OSMF, Lichen planus, leukoplakia and oral cancer
Fig. 2
Fig. 2
Risk of OSMF, Lichenplanus, Leukoplakia and oral cancer with different genotypes and alleles of p16 450 C > G polymorphism. (* p value, 0.05)
Fig. 3
Fig. 3
Level of p16 transcript among the oral cancer, OPMD and healthy control subjects
Fig. 4
Fig. 4
Effect of p16 C > G polymorphism on mRNA secondary structure and corresponding Minimal folding Energy (MFE) predicted by RNAfold

Similar articles

References

    1. National Cancer Institute [Internet]. Surveillance Epidemiology and End Results: SEER Stat Fact Sheets: Oral Cavity and Pharynx - Available from: http://www.seer.cancer.gov/statfacts/html/oralcav.html#incidence-mortality. (2013).
    1. Riley RD, Sauerbrei W, Altman DG. Prognostic markers in cancer: the evolution of evidence from single studies to metaanalysis, and beyond. Br J Cancer. 2009;100:1219–29. - PMC - PubMed
    1. Polanska H, Raudenska M, Gumulec J, et al. Clinical significance of head and neck squamous cell cancer biomarkers. Oral Oncol. 2014;50:168–77. - PubMed
    1. Ghalwash DM. Diagnostic and prognostic value of salivary biomarkers in oral cancer and precancer: review Article. J Oral Maxillofac Surg Med Pathol. 2020;32(6):538–43.
    1. Tanaka T, Ishigamori R. Understanding carcinogenesis for fighting oral cancer. J Oncol. p. 603740 (2011). - PMC - PubMed

LinkOut - more resources